相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it!
Vincent M. Brandenburg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Vitamin K Dependent Proteins in Kidney Disease
Ciprian N. Silaghi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Serum sclerostin: relation with mortality and impact of hemodiafiltration
Lotte Lips et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Radial artery sclerostin expression in chronic kidney disease stage 5 predialysis patients: a cross-sectional observational study
Hua Zhou et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2017)
The Lrp4 R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans
Eveline Boudin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone
Igor Fijalkowski et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells
Mayumi Ukita et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
S. Pelletier et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Warfarin Induces Cardiovascular Damage in Mice
Thilo Krueger et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Smooth Muscle Cell Plasticity Fact or Fiction?
Anh T. Nguyen et al.
CIRCULATION RESEARCH (2013)
Sclerostin: Another Vascular Calcification Inhibitor?
Kathleen J. Claes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
Liesbeth Viaene et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
Vincent M. Brandenburg et al.
BMC NEPHROLOGY (2013)
Transglutaminase 2-Mediated Activation of β-Catenin Signaling Has a Critical Role in Warfarin-Induced Vascular Calcification
Kelly E. Beazley et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
SCLEROSTIN AS POTENTIAL NOVEL BIOMARKER FOR AORTIC VALVE CALCIFICATION
Ralf Koos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells
Estelle Woldt et al.
NATURE COMMUNICATIONS (2012)
Cell-specific effects of TNF-α and IL-1β on alkaline phosphatase: implication for syndesmophyte formation and vascular calcification
Philippe Lencel et al.
LABORATORY INVESTIGATION (2011)
The Appearance and Modulation of Osteocyte Marker Expression during Calcification of Vascular Smooth Muscle Cells
Dongxing Zhu et al.
PLOS ONE (2011)
Minimal Peroxide Exposure of Neuronal Cells Induces Multifaceted Adaptive Responses
Wayne Chadwick et al.
PLOS ONE (2010)
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Matrix Gla-protein: The calcification inhibitor in need of vitamin K
Leon J. Schurgers et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Smooth muscle cell phenotypic transition associated with calcification - Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers
SA Steitz et al.
CIRCULATION RESEARCH (2001)
分享论文
